Orchard Therapeutics PLC Sponsored ADR EPS - Earnings per Share 2019-2023 | ORTX
Orchard Therapeutics PLC Sponsored ADR eps - earnings per share from 2019 to 2023. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Orchard Therapeutics PLC Sponsored ADR Annual EPS |
| 2022 |
$-1.18 |
| 2021 |
$-1.17 |
| 2020 |
$-15.30 |
| 2019 |
$-17.50 |
| 2018 |
$-102.20 |
| 2017 |
$-44.80 |
| 2016 |
$-21.50 |
| Orchard Therapeutics PLC Sponsored ADR Quarterly EPS |
| 2023-09-30 |
$-1.55 |
| 2023-06-30 |
$-0.65 |
| 2023-03-31 |
$-1.20 |
| 2022-12-31 |
$10.01 |
| 2022-09-30 |
$-3.71 |
| 2022-06-30 |
$-3.98 |
| 2022-03-31 |
$-3.50 |
| 2021-12-31 |
$7.73 |
| 2021-09-30 |
$-2.90 |
| 2021-06-30 |
$-2.90 |
| 2021-03-31 |
$-3.10 |
| 2020-12-31 |
$-3.40 |
| 2020-09-30 |
$-2.00 |
| 2020-06-30 |
$-4.80 |
| 2020-03-31 |
$-5.10 |
| 2019-12-31 |
$-4.60 |
| 2019-09-30 |
$-3.80 |
| 2019-06-30 |
$-5.60 |
| 2019-03-31 |
$-3.50 |
| 2018-12-31 |
$100.50 |
| 2018-09-30 |
$-32.90 |
| 2018-06-30 |
$-154.50 |
| 2018-03-31 |
$-15.30 |
